Limba
Romanian
Romanian
English|
Avadomide (CC-122), a new chemical entity termed pleiotropic pathway modifier, is a novel agent for Diffuse large B-cell lymphoma(DLBCL) with antitumor and immunomodulatory activity. Its molecular target is the protein cereblon(CRBN), a substrate receptor of the cullin ring E3 ubiquitin ligase complex CRL4CRBN.
| Price | 992,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Avadomide (CC-122), a new chemical entity termed pleiotropic pathway modifier, is a novel agent for Diffuse large B-cell lymphoma(DLBCL) with antitumor and immunomodulatory activity. Its molecular target is the protein cereblon(CRBN), a substrate receptor of the cullin ring E3 ubiquitin ligase complex CRL4CRBN. |
